IBD
Conditions
Brief summary
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Detailed description
none considered needed
Interventions
None listed
Sponsors
Helse Stavanger HF
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* newly diagnosed IBD
Exclusion criteria
* previous IBD with specific treatment within 10 year * inability to consent * inability to adhere to treatment protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical efficacy of IBD drug therapy | 5 years | Endoscopic, clinical and biochemical response |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fatigue in patients with coeliac disease - substudy | 1 year | Fatigue severity and prevalence at diagnosis and after one year of gluten free diet |
| Fatigue in IBD | 5 years | Fatigue severity and prevalence at diagnosis and during follow-up |
| IBD and the intestinal microbiome | 5 years | Microbiome/eukaryome profiles associated with disease activity and treatment response from diagnosis and during follow-up |
Countries
Norway
Contacts
Primary Contacttore grimstad
Backup Contactlars aabakken
Outcome results
None listed